🇺🇸 FDA
Pipeline program

Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick control negativo, Diagnóstico prick control positivo

API-EAL-2024-01

Phase 2 small_molecule active

Quick answer

Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick Lepidoglyphus destructor, Diagnóstico prick control negativo, Diagnóstico prick control positivo for Allergies is a Phase 2 program (small_molecule) at Advanced Accelerator Applications with 1 ClinicalTrials.gov record(s).

Program details

Company
Advanced Accelerator Applications
Indication
Allergies
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials